Cortico-thalamic Glutamate/GABA mRNA in schizophrenia

精神分裂症中的皮质丘脑谷氨酸/GABA mRNA

基本信息

项目摘要

DESCRIPTION (provided by applicant): Glutamatergic/GABAergic system abnormalities in the cerebral cortex and morphological/anatomical/biochemical abnormalities in the thalamus are present in schizophrenia. Some of the evidence comes from studies conducted in our laboratories showing changes in the expression of mRNAs encoding for ionotropic glutamate receptor genes in both the thalamus and the cortex, and for the GABA synthesizing enzyme glutamic acid decarboxylase (GAD-65 and GAD-67). Studies on the same brain specimens derived from extremely well characterized neuropsychiatrically and neuropathologically assessed schizophrenic subjects has shown that GAD mRNA level changes are reflected in functional abnormalities in the activity of GAD. The studies proposed aim to determine whether glutamatergic/GABAergic abnormalities in the neocortex are associated with glutamatergic/GABAergic abnormalities in the thalamus. Brain tissue specimens will be derived from: Dorsolateral prefrontal cortex (DLPFC) and the mediodorsal nucleus (MDN) of the thalamus; Cingulate cortex and the anterior group of thalamic nuclei; Precentral cortex (Brodmann 4/6) and the ventrolateral nuclear group of the thalamus; Inferior temporal gyrus (Brodmann 20) and the pulvinar; and Striate / Visual cortex (Brodmann 17) and the lateral geniculate nucleus of the thalamus. These specimens will be derived from 37 normal controls, 32 antemortem assessed and diagnosed schizophrenics who have been neuropathologically characterized to be free of any confounding neuropathological lesions, and 15 Alzheimer disease cases for comparative purposes. We will test hypotheses designed to determine whether glutamatergic and GABAergic abnormalities (mRNA and protein) in specific thalamic nuclei are associated with glutamatergic and GABAergic abnormalities in specific cortical regions and vice versa. In addition, studies in rats will test the hypothesis that the glutamatergic and GABAergic abnormalities in the prefrontal cortex are a direct result of lesions in the MDN.
描述(由申请人提供):丘脑丘脑中存在脑皮质和形态/解剖学/生化异常的谷氨酸/GABA能系统异常。 一些证据来自在我们的实验室中进行的研究,表明丘脑和皮质中的离子型谷氨酸受体基因的mRNA表达变化,以及GABA合成酶谷氨酸十羧酸酶(GAD-65和GAD-65和GAD-67)的GABA合成酶。对来自极为表征的神经精神和神经病理学评估的精神分裂症受试者的相同大脑标本的研究表明,GAD mRNA水平的变化反映在GAD活性中的功能异常中。研究旨在确定新皮层中的谷氨酸能/GABA能异常是否与丘脑中的谷氨酸能/GABA能异常有关。脑组织标本将源自:丘脑的背外侧前额叶皮层(DLPFC)和中型核(MDN);扣带皮层和丘脑核的前组;丘脑前后皮层(Brodmann 4/6)和丘脑的腹外侧核群;下颞回(Brodmann 20)和Pulvinar;丘脑的侧面 /视觉皮层(Brodmann 17)和侧向核核。这些标本将源自37个正常对照,32个被评估和诊断为神经病理学的精神分裂症患者,这些精神分裂症患者在神经病理学上表征不含任何混杂的神经病理病变,以及15例阿尔茨海默氏病病例,以进行比较。我们将检验旨在确定特定丘脑核中谷氨酸能和GABA能异常(mRNA和蛋白)是否与特定皮质区域的谷氨酸能和GABA能异常相关的假设,而visea是与谷氨酸能和GABA能异常有关的。此外,对大鼠的研究将检验以下假设:前额叶皮层中谷氨酸能和GABA能异常是MDN病变的直接结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VAHRAM HAROUTUNIAN其他文献

VAHRAM HAROUTUNIAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VAHRAM HAROUTUNIAN', 18)}}的其他基金

NIH BRAIN AND TISSUE RESPOSITORY (NBTR)
美国国立卫生研究院 (NIH) 脑和组织存储库 (NBTR)
  • 批准号:
    10916989
  • 财政年份:
    2023
  • 资助金额:
    $ 27.63万
  • 项目类别:
The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease
阿尔茨海默病跨多个组织的适应性先天免疫相互作用组
  • 批准号:
    10662733
  • 财政年份:
    2023
  • 资助金额:
    $ 27.63万
  • 项目类别:
Single-nucleus transcriptome profiling across multiple brain regions in Parkinson's Disease
帕金森病多个脑区的单核转录组分析
  • 批准号:
    10372330
  • 财政年份:
    2021
  • 资助金额:
    $ 27.63万
  • 项目类别:
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
FSH 升高——阿尔茨海默病性别差异的驱动因素
  • 批准号:
    10302046
  • 财政年份:
    2021
  • 资助金额:
    $ 27.63万
  • 项目类别:
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
FSH 升高——阿尔茨海默病性别差异的驱动因素
  • 批准号:
    10685326
  • 财政年份:
    2021
  • 资助金额:
    $ 27.63万
  • 项目类别:
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
FSH 升高——阿尔茨海默病性别差异的驱动因素
  • 批准号:
    10495197
  • 财政年份:
    2021
  • 资助金额:
    $ 27.63万
  • 项目类别:
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
了解人脑免疫细胞在阿尔茨海默病中的保护和神经炎症作用
  • 批准号:
    10412322
  • 财政年份:
    2020
  • 资助金额:
    $ 27.63万
  • 项目类别:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
本合同的目的是建立收集站点(即 NIH 大脑和组织存储库 (NBTR)),以提供积极获取、接收、处理、存储、整理、预检的服务
  • 批准号:
    10473437
  • 财政年份:
    2020
  • 资助金额:
    $ 27.63万
  • 项目类别:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
本合同的目的是建立收集站点(即 NIH 大脑和组织存储库 (NBTR)),以提供积极获取、接收、处理、存储、整理、预检的服务
  • 批准号:
    10685914
  • 财政年份:
    2020
  • 资助金额:
    $ 27.63万
  • 项目类别:
Neuropathology Core
神经病理学核心
  • 批准号:
    10614010
  • 财政年份:
    2020
  • 资助金额:
    $ 27.63万
  • 项目类别:

相似海外基金

Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
  • 批准号:
    10676358
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
  • 批准号:
    10752555
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
  • 批准号:
    10748606
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
  • 批准号:
    10462257
  • 财政年份:
    2023
  • 资助金额:
    $ 27.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了